Results
|
|
3741.
|
|
|
|
3742.
|
|
|
|
3743.
|
A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome. [electronic resource] by
- Gaztanaga, Juan
- Farkouh, Michael
- Rudd, James H F
- Brotz, Tilmann M
- Rosenbaum, David
- Mani, Venkatesh
- Kerwin, Todd C
- Taub, Rebecca
- Tardif, Jean-Claude
- Tawakol, Ahmed
- Fayad, Zahi A
Producer: 20160105
In:
Atherosclerosis vol. 240
Availability: No items available.
|
|
|
3744.
|
Synthesis and biological evaluation of novel 5-hydroxylaminoisoxazole derivatives as lipoxygenase inhibitors and metabolism enhancing agents. [electronic resource] by
- Averina, Elena B
- Vasilenko, Dmitry A
- Gracheva, Yulia A
- Grishin, Yuri K
- Radchenko, Eugene V
- Burmistrov, Vladimir V
- Butov, Gennady M
- Neganova, Margarita E
- Serkova, Tatyana P
- Redkozubova, Olga M
- Shevtsova, Elena F
- Milaeva, Elena R
- Kuznetsova, Tamara S
- Zefirov, Nikolay S
Producer: 20161020
In:
Bioorganic & medicinal chemistry vol. 24
Availability: No items available.
|
|
|
3745.
|
5-lipoxygenase activation is involved in the mechanisms of chronic hepatic injury in a rat model of chronic aluminum overload exposure. [electronic resource] by
- Mai, Shaoshan
- He, Qin
- Wang, Hong
- Hu, Xinyue
- Luo, Ying
- Yang, Yang
- Kuang, Shengnan
- Tian, Xiaoyan
- Ma, Jie
- Yang, Junqing
Producer: 20170529
In:
Toxicology and applied pharmacology vol. 305
Availability: No items available.
|
|
|
3746.
|
|
|
|
3747.
|
|
|
|
3748.
|
|
|
|
3749.
|
|
|
|
3750.
|
|
|
|
3751.
|
|
|
|
3752.
|
|
|
|
3753.
|
|
|
|
3754.
|
|
|
|
3755.
|
|
|
|
3756.
|
|
|
|
3757.
|
|
|
|
3758.
|
|
|
|
3759.
|
|
|
|
3760.
|
|